H&Q Asia Pacific
Overview
H&Q Asia Pacific (H&QAP) is an Asian private equity firm that conducts both later-stage control investments and earlier-stage venture capital investments . It focuses on growth sectors including technology, technology manufacturing, consumer brands and financial services . H&QAP is dedicated to identifying superior commercial potential in Asia and working closely with companies to unlock that untapped potential .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| One Inc | Dec 2016 | Series B | Co-investor |
| PayEase | Dec 2014 | Series E | Co-investor |
| Silicon Genesis Corporation | Mar 2016 | VC Round | Co-investor |
| PhiSkin | - | Series A | Lead |
| EOC Pharma | Nov 2017 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is H&Q Asia Pacific based?
H&Q Asia Pacific is headquartered in Hong Kong, Hong Kong, Hong Kong.
When was H&Q Asia Pacific founded?
H&Q Asia Pacific was founded in 1985.
How many portfolio companies does H&Q Asia Pacific have?
H&Q Asia Pacific has 5 portfolio companies in Caplight's dataset.
What are some companies in H&Q Asia Pacific's portfolio?
Portfolio companies visible on Caplight include One Inc, PayEase, Silicon Genesis Corporation, PhiSkin, EOC Pharma.
What was H&Q Asia Pacific's most recent investment shown here?
H&Q Asia Pacific's most recent investment in this portfolio sample was in EOC Pharma in 2017.
What sectors does H&Q Asia Pacific focus on?
H&Q Asia Pacific focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, Frontier & Industrial Tech, FinTech, Telecommunications & Networking, Enterprise Software, Consumer & Commerce.
What company stages does H&Q Asia Pacific focus on?
H&Q Asia Pacific typically invests at the Mid stage.
What is H&Q Asia Pacific's AUM?
H&Q Asia Pacific's assets under management are estimated between $1.0B and $10.0B.